Oxygenated fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function.
D000800:Angioplasty, Balloon / Q000009:adverse effects / Q000379:methods*; D001802:Blood Substitutes / Q000008:administration & dosage; D003327:Coronary Disease / Q000517:prevention & control*; D004338:Drug Combinations / Q000008:administration & dosage; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D007263:Infusions, Parenteral; D008297:Male; D013997:Time Factors
D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination